PMID: 2496815Mar 18, 1989Paper

Effect of melatonin on jet lag after long haul flights

BMJ : British Medical Journal
K PetrieK Chamberlain

Abstract

To determine whether doses of the pineal hormone melatonin alleviate jet lag. Double blind, placebo controlled crossover trial. Long haul return flights from Auckland, New Zealand, to London and back. Twenty volunteers with experience of transcontinental flights (eight women and 12 men aged 28 to 68). Melatonin (or placebo) 5 mg three days before flight, during flight, and once a day for three days after arrival. Symptoms of jet lag. Visual analogue scale for feelings of jet lag and tiredness; profile of moods states questionnaire for vigour-activity and fatigue-inertia; and retrospective ratings 10 days after arrival of sleep pattern, energy, and daytime tiredness. Feelings of jet lag were less for subjects taking melatonin (mean score 2.15 v 3.4); these subjects took fewer days than the placebo group to establish a normal sleep pattern (2.85 v 4.15), to not feel tired during the day (3.0 v 4.6), and to reach normal energy levels (3.25 v 4.7). Results for fatigue-inertia and vigour-activity were similar. For all subjects jet lag was more severe on the return (westward) than the outward (eastward) journey. Melatonin can alleviate jet lag and tiredness after long haul flights.

References

Aug 1, 1979·Pflügers Archiv : European journal of physiology·R A Wever
Nov 22, 1986·Lancet·A N NicholsonT Roth
Jan 16, 1982·British Medical Journal·J Arendt, V Marks
Aug 6, 1983·British Medical Journal·J Arendt, V Marks
Feb 6, 1981·JAMA : the Journal of the American Medical Association·R W EvansF A Bryan
Apr 1, 1983·Biopharmaceutics & Drug Disposition·L E Mather, K L Austin

❮ Previous
Next ❯

Citations

Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·A A BorbélyI Oswald
Jan 1, 1993·Psychopharmacology·A B DollinsH R Lieberman
Sep 10, 2010·Advances in Therapy·Venkatramanujam SrinivasanDaniel P Cardinali
Oct 15, 1992·Biological Psychiatry·B ClaustratG Chazot
Oct 15, 1993·Biological Psychiatry·A LinoA C Rusconi
Jan 1, 1994·Biological Psychiatry·J Arendt
Jun 24, 1993·European Journal of Pharmacology·D A GolombekD P Cardinali
Sep 1, 1993·Pharmacology, Biochemistry, and Behavior·S M ArmstrongJ R Redman
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·D A GolombekD P Cardinali
Jan 1, 1996·Pharmacology & Therapeutics·D Dawson, S M Armstrong
Jan 1, 1995·Neurophysiologie clinique = Clinical neurophysiology·B ClaustratG Chazot
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·K K KandimallaM Singh
Aug 18, 2004·Sleep Medicine Reviews·I Haimov, J Arendt
Nov 1, 2003·Sleep Medicine·A O JamiesonJ K Walsh
Feb 24, 2001·Psychiatry and Clinical Neurosciences·T TakahashiH Sano
Feb 5, 2010·The New England Journal of Medicine·Robert L Sack
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·A B DollinsM H Deng
Nov 18, 2000·Ergonomics·J WaterhouseR Godfrey
Jan 22, 2002·Clinical Neuropharmacology·K Satoh, K Mishima
Dec 1, 1995·Journal of Sleep Research·J ArendtL Morgan
Aug 25, 2000·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·M JockovichD C Seaberg
Aug 7, 1998·Journal of Pineal Research·N L RogersD Dawson
Apr 30, 1998·British Journal of Sports Medicine·M YoungD MacAuley
Jun 19, 1998·British Journal of Sports Medicine·R ManfrediniF Conconi
Jun 4, 1999·Journal of Clinical Pharmacology·J ShahS K Gupta
Oct 30, 2008·Journal of Circadian Rhythms·Khosro Sadeghniiat-HaghighiZohreh Yazdi
Jan 29, 2002·Anesthesia and Analgesia·Michael Hanania, Eric Kitain
Aug 23, 2003·Anesthesia and Analgesia·Mohamed NaguibMarc Gregerson
Sep 29, 2001·Journal of Physiological Anthropology and Applied Human Science·R AhasanA Salmoni
Sep 10, 2003·Sports Medicine·Greg AtkinsonJim Waterhouse
Jan 1, 1990·Neurochemistry International·R E Rosenstein, D P Cardinali
Jan 1, 1994·Brain & Development·A TomodaT Kawasaki
Apr 25, 2007·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Jennifer Lee JenkinsNelson Tang
Aug 8, 2008·Drug Delivery·R Jayachandra BabuMandip Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.